CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | Rodino-Klapac Louise President, R&D and Tech Ops | Shares withheld for taxes | −4,582 | $18.42 | $84K | 224,030 |
| 2025-09-03 | Rodino-Klapac Louise President, R&D and Tech Ops | Grant or award | +93,875 | 178,612 | ||
| 2025-09-03 | Rodino-Klapac Louise President, R&D and Tech Ops | Grant or award | +50,000 | 228,612 | ||
| 2025-09-03 | Wong Ryan Ho-Yan Chief Financial Officer | Grant or award | +93,875 | 111,203 | ||
| 2025-09-03 | Wong Ryan Ho-Yan Chief Financial Officer | Grant or award | +25,000 | 136,203 | ||
| 2025-09-03 | Estepan Ian Michael Chief Operating Officer | Grant or award | +93,875 | 156,487 | ||
| 2025-09-03 | Estepan Ian Michael Chief Operating Officer | Grant or award | +50,000 | 206,487 | ||
| 2025-09-03 | Rothfuss Cristin EVP, General Counsel | Grant or award | +93,875 | 114,985 | ||
| 2025-09-03 | Rothfuss Cristin EVP, General Counsel | Grant or award | +25,000 | 139,985 | ||
| 2025-08-05 | Arif Bilal Chief Tech Ops Officer | Grant or award · Performance Stock Units | +6,250 | 6,250 | ||
| 2025-08-05 | Estepan Ian Michael Chief Operating Officer | Grant or award · Performance Stock Units | +6,250 | 6,250 | ||
| 2025-08-05 | Rodino-Klapac Louise President, R&D and Tech Ops | Grant or award · Performance Stock Units | +6,250 | 6,250 | ||
| 2025-07-31 | Wong Ryan Ho-Yan Chief Financial Officer | Shares withheld for taxes | −327 | $16.42 | $5K | 17,328 |
| 2025-05-16 | Barry Richard Director | Option exercise | +12,350 | $32.63 | $403K | 2,966,667 |
| 2025-05-16 | Barry Richard Director | Option exercise · Stock Option (right to buy) | −12,350 | 0 | ||
| 2025-05-13 | Barry Richard Director | Option exercise | +9,746 | $25.18 | $245K | 2,943,817 |
| 2025-05-13 | Barry Richard Director | Option exercise | +10,500 | $13.71 | $144K | 2,954,317 |
| 2025-05-13 | Barry Richard Director | Option exercise · Stock Option (right to buy) | −9,746 | 0 | ||
| 2025-05-13 | Barry Richard Director | Option exercise · Stock Option (right to buy) | −10,500 | 0 | ||
| 2025-03-12 | Nicaise Claude Director | Option exercise | +9,746 | $25.18 | $245K | 30,303 |
Page 4 of 12 · 227 trades